Article
β-Arrestin-2 Counters CXCR7-Mediated EGFR Transactivation and Proliferation.
Molecular cancer research : MCR - 1 May 2016
Kallifatidis Georgios, Munoz Daniel, Singh Rajendra Kumar, Salazar Nicole, Hoy James J, Lokeshwar Bal L
Abstract excerpt
UNLABELLED: The atypical 7-transmembrane chemokine receptor, CXCR7, transactivates the EGFR leading to increased tumor growth in several tumor types. However, the molecular mechanism of CXCR7 ligand-independent EGFR transactivation is unknown. We used cDNA knock-in, RNAi and analysis of mitogenic signaling components in both normal prostate epithelial cells and prostate cancer cells to decipher the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
